Cargando…
CDK4/6 inhibition suppresses tumour growth and enhances the effect of temozolomide in glioma cells
In adults, glioma is the most commonly occurring and invasive brain tumour. For malignant gliomas, the current advanced chemotherapy includes TMZ (temozolomide). However, a sizeable number of gliomas are unyielding to TMZ, hence, giving rise to an urgent need for more efficient treatment choices. He...
Autores principales: | Cao, Yingxiao, Li, Xin, Kong, Shiqi, Shang, Shuling, Qi, Yanhui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7205809/ https://www.ncbi.nlm.nih.gov/pubmed/32277580 http://dx.doi.org/10.1111/jcmm.15156 |
Ejemplares similares
-
Lestaurtinib potentiates TRAIL‐induced apoptosis in glioma via CHOP‐dependent DR5 induction
por: Cao, Yingxiao, et al.
Publicado: (2020) -
miR‐152‐5p suppresses glioma progression and tumorigenesis and potentiates temozolomide sensitivity by targeting FBXL7
por: Kong, Shiqi, et al.
Publicado: (2020) -
MiR‐3116 sensitizes glioma cells to temozolomide by targeting FGFR1 and regulating the FGFR1/PI3K/AKT pathway
por: Kong, Shiqi, et al.
Publicado: (2020) -
miR‐1254 inhibits progression of glioma in vivo and in vitro by targeting CSF‐1
por: Li, Xin, et al.
Publicado: (2020) -
Fasudil increases temozolomide sensitivity and suppresses temozolomide-resistant glioma growth via inhibiting ROCK2/ABCG2
por: Zhang, Xin, et al.
Publicado: (2018)